HighlightLL Pharma Funding: $38M Raised, Series B (2021)
HighlightLL Pharma is based in Hangzhou, China. It has raised $38M in total funding. Latest round: Series B.
HighlightLL Pharma funding overview
HighlightLL Pharma is based in Hangzhou, China. HighlightLL Pharma has raised $38M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in July 2021. The round record for HighlightLL Pharma runs through 2021; nothing later has been disclosed. Investors on record include Hankang Capital, Kaitai Capital, eFung Capital, Lakeside Capital. 4 distinct backers are named across the disclosed rounds.
HighlightLL Pharma at a glance
Total raised
$38M
Latest round
Series B
Latest round date
July 2021
Headquarters
Hangzhou, China
Notable investors
Hankang Capital, Kaitai Capital, eFung Capital, Lakeside Capital
Frequently asked about HighlightLL Pharma funding
How much has HighlightLL Pharma raised?
HighlightLL Pharma has raised $38M in total disclosed funding across the rounds on record.
Who has invested in HighlightLL Pharma?
Hankang Capital, Kaitai Capital, eFung Capital, Lakeside Capital are named among the investors backing HighlightLL Pharma.
What was the latest HighlightLL Pharma funding round?
The most recent disclosed round is a Series B, announced in July 2021.
Where is HighlightLL Pharma based?
HighlightLL Pharma is based in Hangzhou, China.
When did HighlightLL Pharma last raise?
The last disclosed HighlightLL Pharma round closed in July 2021 at Series B.
We update the HighlightLL Pharma record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Hangzhou and their backers are listed below.
